Cipher Pharmaceuticals
6560 Kennedy Road
Mississauga
Ontario
L5T 2X4
Canada
Tel: 905-565-0043
Fax: 905-565-1776
230 articles with Cipher Pharmaceuticals
-
Cipher Pharma Proposes Adding Robert Tessarolo And Arthur Deboeck To Board Of Directors
4/12/2017
-
Cipher Pharma Announces Amendment To Debt Agreement And Partial Prepayment
4/3/2017
-
Former Celgene Exec to Helm Cipher Pharma
3/22/2017
-
Cipher Pharma Reports 2016 Q4 & Year-End Financial Results
3/2/2017
-
Notice Of Cipher Pharma Q4 And Year-End 2016 Conference Call
2/17/2017
-
Cipher Pharma Announces Plans To Voluntarily Delist From NASDAQ
11/29/2016
-
Cipher Pharma Reports Q3 2016 Financial Results
11/11/2016
-
Cipher Pharma Announces Management Change
11/11/2016
-
Cipher Pharma Responds To Request For Comment From IIROC
10/31/2016
-
Notice Of Cipher Pharma Q3 2016 Conference Call
10/27/2016
-
Cipher Pharma Brings Aboard Former Nuvo Pharma Exec as New CFO
9/2/2016
-
Cipher Pharma Reports Q2 2016 Results Highlighted By 32% Revenue Growth And $3.1 Million Cash From Operations
8/10/2016
-
Cipher Pharma Shakes Up Board as Four Members Step Down, Effective Immediately
8/9/2016
-
Cipher Pharma Announces Preliminary Q2 2016 Results Highlighted By 30+% Revenue Growth And $3.0+Million Cash From Operations
8/3/2016
-
Notice Of Cipher Pharma Q2 2016 Conference Call
7/20/2016
-
Cipher Pharma Announces Ozenoxacin Accepted For Review By Health Canada
7/12/2016
-
Special Committee Of Cipher Pharma Responds To Early Warning Report Filed By 1207407 Ontario Limited
7/6/2016
-
Special Committee Of Cipher Pharma Responds To Early Warning Report Filed By 1207407 Ontario Limited
7/6/2016
-
Cipher Pharma Out-Licenses Rights To ASF-1096 For Anorectal Disorders
6/20/2016
-
Cipher Pharma To Present At Two Upcoming U.S. Investor Conferences
5/31/2016